Olema Pharmaceuticals, Inc.

Healthcare

NASDAQ:OLMA · NASDAQ Global Select

Market Cap $830.67M Beta 2.00 P/E (TTM) -5.1

$9.51 -2.70%

-$0.26 today

52W Low $4.02High $36.26

Vol 2.87M · Avg 1.27M

EPS (TTM) -$1.80Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+126.97%

Period High

$35.83

Period Low

$4.19

Latest

$9.51

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

$1.44B

Absci Corporation

NASDAQ:ABSI

$1.14B

Ventyx Biosciences, Inc.

VTYX

$1.00B

Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

$991.43M

Lexicon Pharmaceuticals, Inc.

NASDAQ:LXRX

$882.35M

4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

$499.32M

Prothena Corporation plc

NASDAQ:PRTA

$458.61M

REGENXBIO Inc.

NASDAQ:RGNX

$414.54M

Verastem, Inc.

NASDAQ:VSTM

$287.65M

Gossamer Bio, Inc.

GOSS

$39.31M

What is the latest OLMA filing?

The latest filing shown is 8-K dated May 26, 2026.

How many recent filings does OLMA have?

Intrinsic Alpha currently shows 20 recent filings for OLMA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.